Amvuttra 25 mg/0.5 mL prefilled syringe Images
Generic Name: vutrisiran
This medication has been identified as Amvuttra 25 mg/0.5 mL prefilled syringe. It is supplied by Alnylam Pharmaceuticals, Inc.
Amvuttra is used in the treatment of Hereditary Amyloidosis and belongs to the drug class miscellaneous metabolic agents. Amvuttra 25 mg/0.5 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Amvuttra
- Generic Name
- vutrisiran
- Strength
- 25 mg/0.5 mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alnylam Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71336-1003
More about Amvuttra (vutrisiran)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
